• M. M. Cherney*, F. Lecaille*, M. Kienetz, F. Nallaseth, Z. Li, M. N. G. James & D. Brömme. Structural analysis of cathepsin K/chondroitin 4-sulfate interactions. (2011) J. Biol. Chem. 286, 8988-8998. doi: 10.1074/jbc.M110.126706                * co-premiers auteurs. 
  • M. Kasabova, A. Saïdi, C. Naudin, J. Sage, F. Lecaille & G. Lalmanach. Cysteine cathepsins: markers and therapeutic targets in lung disorders. (2011) Clinic. Rev. Bone Miner. Metab. 9, 148-161.
  • C. Naudin, A. Joulin-Giet, G. Couetdic, P. Plesiat, A. Szymanska, E. Gorna, F. Gauthier, F. Kasprzykowski, F. Lecaille & G. Lalmanach. Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis. (2011) PLoS ONE 6, e25577. doi: 10.1371/journal.pone.0025577
  • F. Veillard, A. Saïdi, R. Burden, C. Scott, L. Gillet, F. Lecaille & G. Lalmanach. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. (2011) J. Biol. Chem. 286, 37158-37167.  doi: 10.1074/jbc.M111.284869
  • A. Chaillon, M. Braibant, T. Moreau, S. Thenin, A. Moreau, B. Autran and F. Barin (2011) The V1V2 domain and a N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12. J. Virol. 85, 3642-3648. doi: 10.1128/JVI.02424-10
  • - K. Baranger, M.L. Zani, V. Labas, S. Dallet-Choisy and T. Moreau (2011) Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate. PLos ONE, 2011;6(6):e20976.  doi: 10.1371/journal.pone.0020976
  • - M.L. Zani, A. Tanga, A. Saidi, H. Serrano, S. Dallet-Choisy, K. Baranger and T. Moreau (2011) SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions. Biochem. Soc. Trans., 39, 1441–1446. doi: 10.1042/BST0391441
  • Jégot G, Derache C, Castella S, Lahaouassa H, Pitois E, Remold-O’Donnell E, Kellenberger C, Gauthier F and Korkmaz B. (2011). A substrate-based approach to convert serpinB1 into a specific inhibitor of proteinase 3, the Wegener granulomatosis autoantigen. FASEB J, 25(9), 3019-31.  doi: 10.1096/fj.10-176552
  • Korkmaz B, Jégot G, Lau L, Thorpe M, Pitois E, Juliano L, Walls F. A, Hellman L and Gauthier F. (2011). Discriminating between the activities of human cathepsin G and chymase using intramolecularly quenched fluorogenic FRET substrates. FEBS J, 278(15):2635-46. 
  • Guilleminault L, Carré P, Beau-Salinas F, Taillé C, Crestani B, Diot P, Marchand-Adam S (2011) Asthma unmasked with TNFα blocking drugs. Chest 140, 068-71. doi: 10.1378/chest.10-2350
  • Chaigne B, Perrinaud A, Penaud A, Machet MC, Venel Y, Marchand-Adam S, Machet L. (2011) Melanoma lymph node metastasis occurring simultaneously with multifocal sarcoidosis affecting lymph nodes and the lung: a diagnostic pitfall. Br. J. Dermatol. 21, 798-799. doi: 10.1684/ejd.2011.1457
  • Diot E, Carmier D, Marquette D, Lesire V, Marchand-Adam S and Diot P. (2011) IV Immunoglobulin Might Be Considered as a First-line Treatment of Severe Interstitial Lung Disease Associated With Polymyositis. Chest 140, 562-563. doi: 10.1378/chest.11-0492